These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1421642)

  • 1. Compatibility of ceftazidime and aminophylline admixtures for different methods of intravenous infusion.
    Pleasants RA; Vaughan LM; Williams DM; Fox JL
    Ann Pharmacother; 1992 Oct; 26(10):1221-6. PubMed ID: 1421642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability and compatibility of fluconazole and aminophylline in intravenous admixtures.
    Johnson CE; Jacobson PA; Pillen HA; Woycik CL
    Am J Hosp Pharm; 1993 Apr; 50(4):703-6. PubMed ID: 8470689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compatibility of aminophylline and verapamil in intravenous admixtures.
    Johnson CE; Lloyd CW; Mesaros JL; Rubley GJ
    Am J Hosp Pharm; 1989 Jan; 46(1):97-100. PubMed ID: 2712035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compatibility of aminophylline and methylprednisolone sodium succinate intravenous admixtures.
    Johnson CE; Cohen IA; Craft DA; Lizer MH
    Am J Hosp Pharm; 1986 Jun; 43(6):1482-5. PubMed ID: 3524206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compatibility of Ceftazidime-Avibactam, Ceftolozane-Tazobactam, and Piperacillin-Tazobactam with Vancomycin in Dextrose 5% in Water.
    Meyer K; Santarossa M; Danziger LH; Wenzler E
    Hosp Pharm; 2017 Mar; 52(3):221-228. PubMed ID: 28439137
    [No Abstract]   [Full Text] [Related]  

  • 6. Compatibility and stability of linezolid injection admixed with three cephalosporin antibiotics.
    Xu QA; Trissel LA; Williams KY
    J Am Pharm Assoc (Wash); 2000; 40(4):509-14. PubMed ID: 10932460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous Compatibility of Ceftazidime-Avibactam and Aztreonam Using Simulated and Actual Y-site Administration.
    O'Donnell JN; Xu A; Lodise TP
    Clin Ther; 2020 Aug; 42(8):1580-1586.e2. PubMed ID: 32684326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Examination of stability and compatibility of flucloxacillin (Floxapen) and ceftazidime (Fortum) in two infusion media: relevance for the clinical praxis].
    Thalhammer F; Maier-Salamon A; Jäger W
    Wien Med Wochenschr; 2005 Jul; 155(13-14):337-43. PubMed ID: 16092041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability and compatibility studies of cefaloridine, cefuroxime and ceftazidime with PVC infusion bags.
    Faouzi MA; Dine T; Luyckx M; Gressier B; Brunet C; Goudaliez F; Mallevais ML; Cazin M; Cazin JC
    Pharmazie; 1994 Jun; 49(6):425-7. PubMed ID: 8047543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiochemical properties of aminophylline-dextrose injection admixtures.
    Boddapati S; Yang K; Murty R
    Am J Hosp Pharm; 1982 Jan; 39(1):108-12. PubMed ID: 7055136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fortum stability in different disposable infusion devices by pyridine assay.
    Favetta P; Allombert C; Breysse C; Dufresne C; Guitton J; Bureau J
    J Pharm Biomed Anal; 2002 Mar; 27(6):873-9. PubMed ID: 11836051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The design of oral sustained-release theophylline dosing after conversion from intravenous to oral therapy.
    Yamazaki M; Fukutomi O; Kondo N; Kato Z; Nakashima Y; Shinoda S; Agata H; Kondo T; Imaeda N; Orii T
    Int J Clin Pharmacol Ther; 1994 Nov; 32(11):625-31. PubMed ID: 7874380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability and compatibility of ceftazidime administered by continuous infusion to intensive care patients.
    Servais H; Tulkens PM
    Antimicrob Agents Chemother; 2001 Sep; 45(9):2643-7. PubMed ID: 11502544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nefopam hydrochloride compatibility and stability with selected proton pump inhibitors in bionolyte G5 injection for intravenous infusion.
    Kambia NK; Luyckx M; Dine T; Dupin-Spriet T; Gressier B; Brunet C
    J Clin Pharm Ther; 2009 Feb; 34(1):25-31. PubMed ID: 19125900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aminophylline, salbutamol and combined intravenous infusions in acute severe asthma.
    Evans WV; Monie RD; Crimmins J; Seaton A
    Br J Dis Chest; 1980 Oct; 74(4):385-9. PubMed ID: 7011354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of clindamycin phosphate with aztreonam, ceftazidime sodium, ceftriaxone sodium, or piperacillin sodium in two intravenous solutions.
    Marble DA; Bosso JA; Townsend RJ
    Am J Hosp Pharm; 1986 Jul; 43(7):1732-6. PubMed ID: 3529949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a dual-lumen peripheral catheter on the delivery of known incompatible medications.
    Prince RA; Lucas DS; Fox JL
    Ann Pharmacother; 1998 Sep; 32(9):875-7. PubMed ID: 9762372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of ceftazidime and amino acids in parenteral nutrient solutions.
    Wade CS; Lampasona V; Mullins RE; Parks RB
    Am J Hosp Pharm; 1991 Jul; 48(7):1515-9. PubMed ID: 1909093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compatibility of ciprofloxacin injection with selected drugs and solutions.
    Goodwin SD; Nix DE; Heyd A; Wilton JH
    Am J Hosp Pharm; 1991 Oct; 48(10):2166-71. PubMed ID: 1781473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical compatibility of inotropic and vasoactive agents delivered via a multiple line infusion system.
    Grillo JA; Gonzalez ER; Ramaiya A; Karnes HT; Wells B
    Crit Care Med; 1995 Jun; 23(6):1061-6. PubMed ID: 7774217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.